Product Information
VALACYCLOVIR HCL 500 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2240 per EA under NDC 31722070490. Its NADAC has been published 560 times since Dec 2, 2015.
FDA first approved this application on Apr 8, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Valacyclovir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722070490
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALACYCLOVIR HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203047FDA Approved
4/8/2015
TE Code
AB
On Market Since
5/25/2015
Pharmacological Classes
Price Statistics
The NADAC for VALACYCLOVIR HCL 500 MG TABLET has been published 560 times since Dec 2, 2015, and over the history we have for it it has declined 43.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2240 per EA |
|---|---|
| All-time high | $0.4465 (Jan 13, 2016) |
| All-time low | $0.2043 (Nov 20, 2024) |
| 52-week high | $0.2475 |
| 52-week low | $0.2228 |
| Median price | $0.2882 |
| Average price | $0.2915 |
| Largest weekly change | -22.3% (Nov 20, 2024) |
| Weeks tracked | 560 |
| Tracking since | Dec 2, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALACYCLOVIR HCL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALACYCLOVIR HCL 500 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.2240 per EA (NDC 31722070490), effective Aug 19, 2026.
How has the price of VALACYCLOVIR HCL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALACYCLOVIR HCL 500 MG TABLET has declined 43.7%. It has been tracked across 560 weekly CMS publications since Dec 2, 2015.
What are the highest and lowest recorded NADAC prices for VALACYCLOVIR HCL 500 MG TABLET?
Since Dec 2, 2015, the NADAC for VALACYCLOVIR HCL 500 MG TABLET has ranged from a low of $0.2043 (Nov 20, 2024) to a high of $0.4465 (Jan 13, 2016), with a median of $0.2882 per EA.
Are there cheaper alternatives to VALACYCLOVIR HCL 500 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALACYCLOVIR HCL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALACYCLOVIR HCL 500 MG TABLET?
VALACYCLOVIR HCL 500 MG TABLET (NDC 31722070490) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.